Drug Delivery Insights
Pharmaceutical Drugs Innovations: Revolutionising Biological Drug Delivery
Professor Afzal R Mohammed, Professor of Pharmaceutics at Aston University and advisor to Max Bio+, explores two promising advancements being explored that could revolutionise biological drug delivery: liquid-based delivery and inhalation. Read more
13 Dec 2023
Innovation in Inhalation: The Future of Drug Delivery
Broughton's new inhalation testing service propels inhaled drug delivery into an innovative future. Read more
19 Jun 2023
Broughton speaks to EPM on the latest in inhaled medicines testing
EPM speaks to Chris Allen, CEO of scientific consultancy and Contract Research Organisation (CRO) Broughton, which has just launched a new inhalation testing service. Read more
8 Jun 2023
Answering pharma’s call for smarter solutions with Ready-To-Use vials
Fabio Bertacchini, Senior Director of Product, Proposal and Technical Account Management at Stevanato Group shares how Ready-To-Use vials are answering pharma's call for solutions to aseptic manufacturing challenges. Read more
3 Apr 2023
The future of patient experience: how connected drug delivery will promote inclusivity and adherence
Michael Earl, director, pharmaceutical services at Owen Mumford, examines the benefits that patients are set to receive as the connected drug delivery devices market grows. Read more
6 Feb 2023
Customised excipient blends for capsule to tablet formulations
Dr. Sandeep Kumar, Formulation Development manager, Colorcon, sheds light on how selecting an excipient in early formulation development is critical to developing a robust scalable SOD formulation and can help the transition from capsule to tablet. Read more
8 Dec 2022
Genetically engineered iPSCs offer improved efficiency
AMSBIO has launched a range of genetically engineered Induced Pluripotent Stem Cells (iPSCs) developed to provide improved model fidelity over cell lines and biochemical assays used for drug discovery and cell therapy research. Read more
23 Jul 2024
Aptamer signs agreement with AstraZeneca to Explore Optimer Vehicles for Targeted Delivery of siRNA
Aptamer Group plc, the developer of novel Optimer binders to enable innovation in the life sciences industry, has announced a new agreement with AstraZeneca, a global biopharmaceutical company, to evaluate Optimer fibrotic liver delivery vehicles. Read more
5 Jul 2024
NLC Health Ventures launches new early-stage drug delivery company
NLC Health Ventures, in collaboration with Verily, a precision health technology company, will launch Exolvo Biosciences, a pioneering biotech company delivering the next-generation solution for biologic drug delivery. Read more
3 Jul 2024
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
What’s trending in point-of-care diagnostics?
Commercial director, Rory O’Keeffe, Europlaz, examines the latest innovations that the team believes will be transformative to future clinical pathways. Read more
17 Jul 2024
The Practical Impact of Generative AI in Life Science Manufacturing
Life sciences manufacturers continuously strive for accelerated launch, increased capacity for in-demand medicine, enhanced security of supply and improved sustainability. Read more
16 Jul 2024
A Short Guide to Stability Studies
Paul Barr, Principal Scientist at Broughton, outlines the key factors when it comes to stability testing for drug delivery devices. Read more
28 Jun 2024
How Ready Are You? Annex 1 and the Impact of Primary Packaging
Niamh Bissett, Director, Operations, PMO, West Pharmaceutical Services discusses Annex 1 and the Impact of Primary Packaging in our latest EPM Online insight. Read more
18 Jun 2024
Q&A: Purolite's Felix Solamo
We caught up with Purolite's Felix Solamo to look back on Bio International 2024. Read more
18 Jun 2024
Patent Lifecycle Management is Key for Cell and Gene Therapy Innovators
Justin Wilson, partner and pharmaceuticals & gene therapy sector specialist at European intellectual property law firm Withers & Rogers explores how patent lifecycle management is key for cell and gene therapy innovators. Read more
17 Jun 2024